American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.
Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...